| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Cao,Ting | Chairman | 4.09% | |
| PETER C LUU | Director | 11.81% | DPT Biofund LLC |
| Da Qiao,Bao-Hong | Director | 34.84% | Denka Company Limited |
| Lin Tian | Director | 34.84% | Denka Company Limited |
| Cao,De-Feng | Independent Director | 0.00% | |
| Lai,Yi-Jun | Independent Director | 0.00% | |
| Wang,Huai | Independent Director | 0.00% |
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Operating income | 33,277 | 167,176 | 191,188 |
| Operating cost | 14,558 | 104,709 | 132,193 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
| Operating gross profit (loss) | 18,719 | 62,467 | 58,995 |
| Unrealized profit (loss) on sales of goods | - | - | - |
| Realized profit (loss) on sales of goods | - | - | - |
| Operating gross profit (loss), net | 18,719 | 62,467 | 58,995 |
| Operating expenses | 70,972 | 126,620 | 125,930 |
| Other gain (loss), net | - | - | - |
| Operating profit (loss) | -52,253 | -64,153 | -66,935 |
| Non-operating income and expenses | 11,532 | 5,622 | 13,799 |
| Net profit (loss) before tax | -40,721 | -58,531 | -53,136 |
| Income tax expense (benefits) | 0 | 0 | 0 |
| Net profit (loss) of ongoing business for the current period | -40,721 | -58,531 | -53,136 |
| Profit (loss) of closed units | - | - | - |
| Profit (loss) of non-jointly controlled equity before merger | - | - | - |
| Net profit (loss) for the current period | -40,721 | -58,531 | -53,136 |
| Other comprehensive profit (loss), net | -457 | 1,211 | -2,298 |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
| Total comprehensive profit and loss for the current period | -41,178 | -57,320 | -55,434 |
| Net profit (loss) attributable to owners of parent company | -40,721 | -58,531 | -53,136 |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Net profit (loss) attributable to non-controlling interests | - | - | - |
| Comprehensive profit (loss) attributable to owners of parent company | -41,178 | -57,320 | -55,434 |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Comprehensive profit (loss) attributable to non-controlling interests | - | - | - |
| Basic earnings per share (yuan) | 0 | 0 | 0 |
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net cash inflow (outflow) from operating activities | 82,392 | -29,267 | -71,445 |
| Net cash inflows (outflows) from investing activities | -798 | 16,934 | 42,060 |
| Net cash inflow (outflow) from financing activities | -4,343 | -18,987 | -8,884 |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | 339 | -162 | 340 |
| Increase (decrease) in cash and cash equivalents in the current period | 77,590 | -31,482 | -37,929 |
| Beginning balance of cash and cash equivalents | 278,873 | 310,355 | 348,284 |
| Ending balance of cash and cash equivalents | 356,463 | 278,873 | 310,355 |
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current asset | 563,460 | 478,559 | 547,943 |
| Non-current asset | 31,944 | 38,103 | 34,208 |
| Total asset | 595,404 | 516,662 | 582,151 |
| Current liability | 139,943 | 54,534 | 46,287 |
| Non-current liability | 71,124 | 37,727 | 56,437 |
| Total liability | 211,067 | 92,261 | 102,724 |
| share capital | 1,036,495 | 1,036,495 | 1,036,495 |
| Equity - secruity token | - | - | - |
| capital reserve | 636,646 | 635,532 | 633,238 |
| retained earning | -1,253,948 | -1,213,227 | -1,154,696 |
| Other equity | -34,856 | -34,399 | -35,610 |
| Treasury stock | - | - | - |
| Total equity attributable to owners of parent company | 384,337 | 424,401 | 479,427 |
| Equity attributable to former owner of business combination under common control | - | - | - |
| Equity attributable to non-controlling interest before business merger under common control | - | - | - |
| Non-controlling interests | - | - | - |
| Total Equity | 384,337 | 424,401 | 479,427 |
| Share capital awaiting retirement (unit: share) | 0 | 0 | 0 |
| Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
| Net asset value per share | 3 | 4 | 4 |
